Correlation Between Sarepta Therapeutics and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Agios Pharm, you can compare the effects of market volatilities on Sarepta Therapeutics and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Agios Pharm.
Diversification Opportunities for Sarepta Therapeutics and Agios Pharm
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sarepta and Agios is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Agios Pharm go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Agios Pharm
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 3.09 times less return on investment than Agios Pharm. In addition to that, Sarepta Therapeutics is 1.15 times more volatile than Agios Pharm. It trades about 0.11 of its total potential returns per unit of risk. Agios Pharm is currently generating about 0.38 per unit of volatility. If you would invest 4,487 in Agios Pharm on September 2, 2024 and sell it today you would earn a total of 1,452 from holding Agios Pharm or generate 32.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Agios Pharm
Performance |
| Timeline |
| Sarepta Therapeutics |
| Agios Pharm |
Sarepta Therapeutics and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Agios Pharm
The main advantage of trading using opposite Sarepta Therapeutics and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stocks Directory Find actively traded stocks across global markets |